Chemotherapy plus multitargeted antiangiogenic tyrosine kinase inhibitors or chemotherapy alone in advanced NSCLC: a meta-analysis of randomized controlled trials.
about
The Efficacy of Synchronous Combination of Chemotherapy and EGFR TKIs for the First-Line Treatment of NSCLC: A Systematic AnalysisEfficacy of Addition of Antiangiogenic Agents to Taxanes-Containing Chemotherapy in Advanced Nonsmall-Cell Lung Cancer: A Meta-Analysis and Systemic ReviewAre VEGFR-TKIs effective or safe for patients with advanced non-small cell lung cancer?Angiogenesis inhibitors for the treatment of small cell lung cancer (SCLC): A meta-analysis of 7 randomized controlled trials.Efficacy and safety of angiogenesis inhibitors in advanced non-small cell lung cancer: a systematic review and meta-analysis.Randomized phase II study of pemetrexed/cisplatin with or without axitinib for non-squamous non-small-cell lung cancerLocalization of sunitinib, its metabolites and its target receptors in tumour-bearing mice: a MALDI-MS imaging study.Multi-targeted antiangiogenic tyrosine kinase inhibitors in advanced non-small cell lung cancer: meta-analyses of 20 randomized controlled trials and subgroup analysesEvaluation of Safety and Efficacy of Salvage Therapy With Sunitinib, Docetaxel (Tyxan) and Cisplatinum Followed by Maintenance Vinorelbine for Unresectable/Metastatic Nonsmall Cell Lung Cancer: Stage 1 of a Simon 2 Stage Clinical Trial. [Corrected].Clinical meta-analyses of targeted therapies in adenocarcinoma.Multitargeted antiangiogenic tyrosine kinase inhibitors combined to chemotherapy in metastatic breast cancer: a systematic review and meta-analysis.Update on Cardiovascular Safety of Tyrosine Kinase Inhibitors: With a Special Focus on QT Interval, Left Ventricular Dysfunction and Overall Risk/Benefit.Hyperglycaemia Induced by Novel Anticancer Agents: An Undesirable Complication or a Potential Therapeutic Opportunity?The addition of anti-angiogenic tyrosine kinase inhibitors to chemotherapy for patients with advanced non-small-cell lung cancers: A meta-analysis of randomized trials.Unusual progression of renal cell carcinoma with carcinomatosis peritoneii and Krukenberg tumour and alopecia with sunitinib therapy in young female.
P2860
Q26797117-90C08EE2-89AF-4DB7-9083-8462A6130E0FQ26801118-6A0C0BBB-AE27-430D-9F96-8457CE2A53BFQ28085104-2EDA3495-DEAA-46FF-A366-C2B593AC0E2CQ30235046-81F96E8E-C433-49D1-9952-694C8CC0C91AQ33418555-39AC41DA-4969-42E9-A480-329A943BB0B5Q33598561-702EB02B-AD08-41B8-B975-D6628879AAB2Q35039240-DFFF272E-B1DB-487A-AB22-83E2C38F2F72Q35346839-E78AD990-168A-46A3-BE74-DD0172EDD3D0Q37624187-48EDE114-8FCC-4A31-8389-BF3039D2FC7DQ38077126-C5549E9A-DECB-49C7-9E04-BDA2B2772158Q38190433-DE7939E9-0773-4103-A07D-949AEBEB72B6Q38501976-6B342BE1-34E4-49A2-B46F-D6DFA6DE6584Q39040854-FCD1FC6A-9CB3-419C-A3E3-227131765B26Q45230734-D96A8BE2-5AA1-4960-AFEB-AEB7373F6317Q49766022-C4871312-9F69-4905-B1F4-E215EA5601E7
P2860
Chemotherapy plus multitargeted antiangiogenic tyrosine kinase inhibitors or chemotherapy alone in advanced NSCLC: a meta-analysis of randomized controlled trials.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Chemotherapy plus multitargete ...... randomized controlled trials.
@ast
Chemotherapy plus multitargete ...... randomized controlled trials.
@en
Chemotherapy plus multitargete ...... randomized controlled trials.
@nl
type
label
Chemotherapy plus multitargete ...... randomized controlled trials.
@ast
Chemotherapy plus multitargete ...... randomized controlled trials.
@en
Chemotherapy plus multitargete ...... randomized controlled trials.
@nl
prefLabel
Chemotherapy plus multitargete ...... randomized controlled trials.
@ast
Chemotherapy plus multitargete ...... randomized controlled trials.
@en
Chemotherapy plus multitargete ...... randomized controlled trials.
@nl
P2093
P2860
P1476
Chemotherapy plus multitargete ...... randomized controlled trials.
@en
P2093
Dong-Mei Yuan
Hong-Bing Liu
Tang-Feng Lv
Yong-Ying Xiao
P2860
P2888
P304
P356
10.1007/S00228-012-1333-3
P577
2012-06-24T00:00:00Z
P6179
1043176946